Ribociclib and Endocrine Therapy as Adjuvant Treatment in HR+/HER2− Early Breast Cancer

Interview with Lee S. Schwartzberg MD, FACP

Read the full article here

Source: PracticeUpdate
Categories: General Medicine News, Latest Headlines
Tweets with this article
PracticeUpdate
In conversation with @OncSTATdoc Listen to the full interview here: https://t.co/6Jkl4Uu1Rd https://t.co/3xznBhzCOF

Related Articles